Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Amgen studies AMG-256 for advanced solid tumors in phase I trial

Oct. 14, 2020

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical present new ERK inhibitors

Oct. 13, 2020

New HDAC6 inhibitors discovered at 2681603 Ontario

Oct. 13, 2020

Janssen Pharmaceutica discloses new MAP4K1 inhibitors

Oct. 13, 2020

UBAP2 as potential therapeutic target in pancreatic cancer

Oct. 13, 2020

PENELOPE-B study of palbociclib does not meet primary endpoint

Oct. 13, 2020

Dosing starts in phase I study of AMP-945

Oct. 13, 2020

FKBP9P1 lncRNA is upregulated in HNSCC and its knockdown inhibits malignant progression

Oct. 13, 2020

Enrollment ongoing in phase I/II ASPEN-02 study of ALX-148 plus azacytidine in MDS

Oct. 13, 2020

Vincera signs license agreement with Bayer for early development oncology portfolio

Oct. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...